{
  "DOI": "10.1007/s10689-015-9847-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-015-9847-3",
  "alternative-id": [
    "9847"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Lan",
      "given": "Zhu",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Fu",
      "given": "Dan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yu",
      "given": "Xiuzhang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xi",
      "given": "Mingrong",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        10,
        13
      ]
    ],
    "date-time": "2015-10-13T00:50:06Z",
    "timestamp": 1444697406000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        8,
        15
      ]
    ],
    "date-time": "2023-08-15T05:39:33Z",
    "timestamp": 1692077973000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        8,
        15
      ]
    ],
    "date-time": "2023-08-15T06:10:02Z",
    "timestamp": 1692079802547
  },
  "is-referenced-by-count": 13,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2015,
        10,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2016,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            10,
            12
          ]
        ],
        "date-time": "2015-10-12T00:00:00Z",
        "timestamp": 1444608000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9847-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-015-9847-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9847-3",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "221-230",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2015,
        10,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        10,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.20121",
      "author": "R Siegel",
      "doi-asserted-by": "crossref",
      "first-page": "212",
      "journal-title": "CA Cancer J Clin",
      "key": "9847_CR1",
      "unstructured": "Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236",
      "volume": "61",
      "year": "2011"
    },
    {
      "DOI": "10.3322/caac.21208",
      "author": "R Siegel",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "journal-title": "CA Cancer J Clin.",
      "key": "9847_CR2",
      "unstructured": "Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin. 64:9–29",
      "volume": "64",
      "year": "2014"
    },
    {
      "author": "American Cancer Society",
      "key": "9847_CR3",
      "unstructured": "American Cancer Society (2014) Cancer facts and figures 2014. American Cancer Society, Atlanta",
      "volume-title": "Cancer facts and figures 2014",
      "year": "2014"
    },
    {
      "DOI": "10.3892/mco.2014.279",
      "author": "S Zhen",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "issue": "4",
      "journal-title": "Mol Clin Oncol",
      "key": "9847_CR4",
      "unstructured": "Zhen S, Bian LH, Chang LL, Gao X (2014) Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: a meta-analysis. Mol Clin Oncol 2(4):559–566",
      "volume": "2",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(09)61338-6",
      "author": "BT Hennessy",
      "doi-asserted-by": "crossref",
      "first-page": "1371",
      "issue": "9698",
      "journal-title": "Lancet",
      "key": "9847_CR5",
      "unstructured": "Hennessy BT, Coleman RL, Markman M (2009) Ovarian cancer. Lancet 374(9698):1371–1382",
      "volume": "374",
      "year": "2009"
    },
    {
      "DOI": "10.1097/AOG.0b013e318264f794",
      "author": "LA Baldwin",
      "doi-asserted-by": "crossref",
      "first-page": "612",
      "journal-title": "Obstet Gynecol",
      "key": "9847_CR6",
      "unstructured": "Baldwin LA, Huang B, Miller RW et al (2012) Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol 120:612–618",
      "volume": "120",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2407-12-258",
      "author": "F Li",
      "doi-asserted-by": "crossref",
      "first-page": "258",
      "journal-title": "BMC Cancer",
      "key": "9847_CR7",
      "unstructured": "Li F, Tie R, Chang K et al (2012) Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis. BMC Cancer 12:258",
      "volume": "12",
      "year": "2012"
    },
    {
      "author": "RC Bast Jr",
      "first-page": "274",
      "issue": "Suppl 3",
      "journal-title": "Int J Gynecol Cancer",
      "key": "9847_CR8",
      "unstructured": "Bast RC Jr, Badgwell D, Lu Z et al (2005) New tumor markers: CA125 and beyond. Int J Gynecol Cancer 15(Suppl 3):274–281",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0002-9378(84)90444-7",
      "author": "JM Niloff",
      "doi-asserted-by": "crossref",
      "first-page": "1057",
      "journal-title": "Am J Obstet Gynecol",
      "key": "9847_CR9",
      "unstructured": "Niloff JM, Klug TL, Schaetzl E et al (1984) Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol 148:1057–1058",
      "volume": "148",
      "year": "1984"
    },
    {
      "DOI": "10.1200/JCO.2008.19.2484",
      "author": "Z Yurkovetsky",
      "doi-asserted-by": "crossref",
      "first-page": "2159",
      "journal-title": "J Clin Oncol",
      "key": "9847_CR10",
      "unstructured": "Yurkovetsky Z, Skates S, Lomakin A et al (2010) Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol 28:2159–2166",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s12079-011-0130-6",
      "author": "PH Anborgh",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "journal-title": "J. Cell Commun Signal",
      "key": "9847_CR11",
      "unstructured": "Anborgh PH, Mutrie JC, Tuck AB, Chambers AF (2011) Pre-and post-translational regulation of osteopontin in cancer. J. Cell Commun Signal 5:111",
      "volume": "5",
      "year": "2011"
    },
    {
      "author": "NS Fedarko",
      "first-page": "4060",
      "issue": "12",
      "journal-title": "Clin Cancer Res",
      "key": "9847_CR12",
      "unstructured": "Fedarko NS, Jain A, Karadag A et al (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7(12):4060–4066",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1158/1055-9965.487.13.3",
      "author": "J Koopmann",
      "doi-asserted-by": "crossref",
      "first-page": "487",
      "issue": "3",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9847_CR13",
      "unstructured": "Koopmann J, Fedarko NS, Jain A et al (2004) Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomark Prev 13(3):487–491",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.2144/01303dd05",
      "author": "KK Wong",
      "doi-asserted-by": "crossref",
      "first-page": "670",
      "journal-title": "Biotechniques",
      "key": "9847_CR14",
      "unstructured": "Wong KK, Cheng RS, Mok SC (2001) Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques 30:670–675",
      "volume": "30",
      "year": "2001"
    },
    {
      "key": "9847_CR15",
      "unstructured": "Matsuura M, Suzuki T, Saito T (2007) Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy. Cancer Sci (in press)"
    },
    {
      "DOI": "10.1007/s11373-006-9143-1",
      "author": "L Bao",
      "doi-asserted-by": "crossref",
      "first-page": "373",
      "journal-title": "J Biomed Sci",
      "key": "9847_CR16",
      "unstructured": "Bao L, Sakaguchi H, Fujimoto J et al (2007) Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci 14:373–381",
      "volume": "14",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.287.13.1671",
      "author": "JH Kim",
      "doi-asserted-by": "crossref",
      "first-page": "1671",
      "issue": "13",
      "journal-title": "JAMA",
      "key": "9847_CR17",
      "unstructured": "Kim JH, Skates SJ, Uede T et al (2002) Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 287(13):1671–1679",
      "volume": "287",
      "year": "2002"
    },
    {
      "DOI": "10.7326/0003-4819-155-8-201110180-00009",
      "author": "PF Whiting",
      "doi-asserted-by": "crossref",
      "first-page": "529",
      "issue": "8",
      "journal-title": "Ann Intern Med",
      "key": "9847_CR18",
      "unstructured": "Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536",
      "volume": "155",
      "year": "2011"
    },
    {
      "DOI": "10.1002/sim.1186",
      "author": "JP Higgins",
      "doi-asserted-by": "crossref",
      "first-page": "1539",
      "journal-title": "Stat Med",
      "key": "9847_CR19",
      "unstructured": "Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558",
      "volume": "21",
      "year": "2002"
    },
    {
      "author": "MJ Li",
      "first-page": "691",
      "issue": "04",
      "journal-title": "Prog Mod Biomed",
      "key": "9847_CR20",
      "unstructured": "Li MJ, Yang YQ, Peng CX et al (2013) Significance of OPN combined with CA125 in early diagnosis of ovarian cancer. Prog Mod Biomed 13(04):691–693",
      "volume": "13",
      "year": "2013"
    },
    {
      "author": "YH Zhao",
      "first-page": "2283",
      "issue": "23",
      "journal-title": "J Med Theor Pract",
      "key": "9847_CR21",
      "unstructured": "Zhao YH, Zhang Q, Hao F (2012) The diagnostic values of combined determination of serum tumor markers HE4, OPN and CA125 levels in patients with epithelial ovarian cancer. J Med Theor Pract 25(23):2283–2285",
      "volume": "25",
      "year": "2012"
    },
    {
      "author": "JB Fan",
      "first-page": "225",
      "issue": "03",
      "journal-title": "J Shanxi Med Univ",
      "key": "9847_CR22",
      "unstructured": "Fan JB, Zhang GL, Wu J et al (2012) Clinical value of b-type ultrasonography combined with serum levels of OPN and CA125 in the early diagnosis of ovarian cancer. J Shanxi Med Univ 43(03):225–228",
      "volume": "43",
      "year": "2012"
    },
    {
      "author": "B Yang",
      "first-page": "1742",
      "issue": "9",
      "journal-title": "Prog Mod Biomed",
      "key": "9847_CR23",
      "unstructured": "Yang B, Jia J, Shi DM, Li J, Chen I (2012) Evaluation of selected serum proteins CA125 and OPN as diagnosis of ovarian cancer. Prog Mod Biomed 12(9):1742–1744",
      "volume": "12",
      "year": "2012"
    },
    {
      "author": "JH Yang",
      "first-page": "303",
      "issue": "5",
      "journal-title": "Chin J Fam Plan",
      "key": "9847_CR24",
      "unstructured": "Yang JH, Liu JH, Shun ZP (2007) Detection of osteopontin and CA125 in patients with ovarian cancer and its clinical significance. Chin J Fam Plan 139(5):303–305",
      "volume": "139",
      "year": "2007"
    },
    {
      "author": "FJ Wu",
      "first-page": "1170",
      "issue": "9",
      "journal-title": "Chin J Lab Diagn.",
      "key": "9847_CR25",
      "unstructured": "Wu FJ, Guan S, Huang BY et al (2009) Detection of osteopontin and CA125 in patients with ovarian cancer and its clinical significance. Chin J Lab Diagn. 13(9):1170–1172",
      "volume": "13",
      "year": "2009"
    },
    {
      "author": "YH Zhou",
      "first-page": "35",
      "issue": "04",
      "journal-title": "J Clin Exp Med",
      "key": "9847_CR26",
      "unstructured": "Zhou YH, Wu XF (2008) Significance of OPN combined with CA125 in diagnosis of epithelial ovarian cancer. J Clin Exp Med 07(04):35–37",
      "volume": "07",
      "year": "2008"
    },
    {
      "author": "YJ Zhang",
      "first-page": "2290",
      "issue": "14",
      "journal-title": "Matern Child Healthc China",
      "key": "9847_CR27",
      "unstructured": "Zhang YJ, Yuan ZF (2013) Expression and significance ofHE4, OPN and c-OPN in carcinoma, ascites, serum and urine in patients with epithelial ovarian cancer. Matern Child Healthc China 28(14):2290–2293",
      "volume": "28",
      "year": "2013"
    },
    {
      "author": "Y Wang",
      "first-page": "5937",
      "issue": "30",
      "journal-title": "Prog Mod Biomed",
      "key": "9847_CR28",
      "unstructured": "Wang Y, Wang J, Zhang ZM et al (2013) Clinical significance of serum OPN, HE4 and CA125 levels in patients with ovarian cancer. Prog Mod Biomed 13(30):5937–5940",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1073/pnas.0502178102",
      "author": "G Mor",
      "doi-asserted-by": "crossref",
      "first-page": "7677",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9847_CR29",
      "unstructured": "Mor G, Visintin I, Lai Y et al (2005) Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 102:7677–7682",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1447-0756.2006.00403.x",
      "author": "M Nakae",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "issue": "3",
      "journal-title": "J Obstet Gynaecol Res",
      "key": "9847_CR30",
      "unstructured": "Nakae M, Iwamoto I, Fujino T et al (2006) Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer. J Obstet Gynaecol Res 32(3):309–314",
      "volume": "32",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-0691",
      "author": "I Meinhold-Heerlein",
      "doi-asserted-by": "crossref",
      "first-page": "458",
      "journal-title": "Clin Cancer Res",
      "key": "9847_CR31",
      "unstructured": "Meinhold-Heerlein I, Bauerschlag D, Zhou Y et al (2007) An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma. Clin Cancer Res 13:458–466",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ygyno.2007.10.017",
      "author": "RG Moore",
      "doi-asserted-by": "crossref",
      "first-page": "402",
      "journal-title": "Gynecol Oncol",
      "key": "9847_CR32",
      "unstructured": "Moore RG, Brown AK, Miller MC et al (2008) The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 108:402–408",
      "volume": "108",
      "year": "2008"
    },
    {
      "DOI": "10.1515/cclm-2013-0151",
      "author": "E Bandiera",
      "doi-asserted-by": "crossref",
      "first-page": "1815",
      "journal-title": "Clin Chem Lab Med",
      "key": "9847_CR33",
      "unstructured": "Bandiera E, Zanotti L, Fabricio AS et al (2013) Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. Clin Chem Lab Med 51:1815–1824",
      "volume": "51",
      "year": "2013"
    },
    {
      "DOI": "10.1111/jog.12097",
      "author": "R Moszynski",
      "doi-asserted-by": "crossref",
      "first-page": "1518",
      "issue": "11",
      "journal-title": "J Obstet Gynaecol Res",
      "key": "9847_CR34",
      "unstructured": "Moszynski R, Szubert S, Szpurek D, Michalak S, Sajdak S (2013) Role of osteopontin in differential diagnosis of ovarian tumors. J Obstet Gynaecol Res 39(11):1518–1525",
      "volume": "39",
      "year": "2013"
    },
    {
      "author": "M Milivojevic",
      "first-page": "83",
      "journal-title": "Eur J Gynaecol Oncol",
      "key": "9847_CR35",
      "unstructured": "Milivojevic M, Boskovic V, Atanackovic J et al (2013) Evaluation of osteopontin and CA125 in detection of epithelial ovarian carcinoma. Eur J Gynaecol Oncol 34:83–85",
      "volume": "34",
      "year": "2013"
    },
    {
      "author": "Y Yan",
      "first-page": "440",
      "issue": "04",
      "journal-title": "Chin J Clin Med",
      "key": "9847_CR36",
      "unstructured": "Yan Y, Liu Z, Liu DQ et al (2013) Combination of serum CA125, HE4 and OPN in the diagnosis of ovarian cancer. Chin J Clin Med 20(04):440–442",
      "volume": "20",
      "year": "2013"
    },
    {
      "DOI": "10.1186/1471-2288-6-31",
      "author": "J Zamora",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "journal-title": "BMC Med Res Methodol",
      "key": "9847_CR37",
      "unstructured": "Zamora J, Abraira V, Muriel A et al (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31",
      "volume": "6",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s13277-014-2314-1",
      "author": "YD Wang",
      "doi-asserted-by": "crossref",
      "first-page": "11799",
      "issue": "12",
      "journal-title": "Tumour Biol",
      "key": "9847_CR38",
      "unstructured": "Wang YD, Chen H, Liu HQ, Hao M (2014) Correlation between ovarian neoplasm and serum levels of osteopontin: a meta-analysis. Tumour Biol 35(12):11799–11808",
      "volume": "35",
      "year": "2014"
    },
    {
      "author": "R Jaeschke",
      "first-page": "121",
      "key": "9847_CR39",
      "unstructured": "Jaeschke R, Guyatt G, Lijmer J (2002) Diagnostic tests. In: Guyatt G, Rennie D (eds) Users guides to the medical literature: a manual for evidence-based clinical practice. AMA Press, Chicago, pp 121–140",
      "volume-title": "Users guides to the medical literature: a manual for evidence-based clinical practice",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.rmed.2009.05.017",
      "author": "L Luo",
      "doi-asserted-by": "crossref",
      "first-page": "149",
      "issue": "1",
      "journal-title": "Respir Med",
      "key": "9847_CR40",
      "unstructured": "Luo L, Shi HZ, Liang QL, Jiang J, Qin SM, Deng JM (2010) Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis. Respir Med 104(1):149–156",
      "volume": "104",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ejogrb.2008.08.011",
      "author": "LR Medeiros",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "issue": "2",
      "journal-title": "Eur J Obstet Gynecol Reprod Biol",
      "key": "9847_CR41",
      "unstructured": "Medeiros LR, Rosa DD, da Rosa MI et al (2009) Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol 142(2):99–105",
      "volume": "142",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-07-1569",
      "author": "I Visintin",
      "doi-asserted-by": "crossref",
      "first-page": "1065",
      "journal-title": "Clin Cancer Res",
      "key": "9847_CR42",
      "unstructured": "Visintin I, Feng Z, Longton G et al (2008) Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res 14:1065–1072",
      "volume": "14",
      "year": "2008"
    },
    {
      "author": "J Vrzalova",
      "first-page": "573",
      "journal-title": "Anticancer Res",
      "key": "9847_CR43",
      "unstructured": "Vrzalova J, Prazakova M, Novotny Z et al (2009) Test of ovarian cancer multiplex xMAP technology panel. Anticancer Res 29:573–576",
      "volume": "29",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ygyno.2011.05.039",
      "author": "D Lu",
      "doi-asserted-by": "crossref",
      "first-page": "560",
      "journal-title": "Gynecol Oncol",
      "key": "9847_CR44",
      "unstructured": "Lu D, Kuhn E, Bristow RE et al (2011) Comparison of candidate serologic markers for type I and type II ovarian cancer. Gynecol Oncol 122:560–566",
      "volume": "122",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S1701-2163(16)35273-2",
      "author": "G He",
      "doi-asserted-by": "crossref",
      "first-page": "567",
      "journal-title": "J Obstet Gynaecol Cancer",
      "key": "9847_CR45",
      "unstructured": "He G, Holcroft CA, Beauchamp MC et al (2012) Combination of serum biomarkers to differentiate malignant from benign ovarian tumours. J Obstet Gynaecol Cancer 34:567–574",
      "volume": "34",
      "year": "2012"
    },
    {
      "DOI": "10.1373/clinchem.2007.093195",
      "author": "S Fredriksson",
      "doi-asserted-by": "crossref",
      "first-page": "582",
      "journal-title": "Clin Chem",
      "key": "9847_CR46",
      "unstructured": "Fredriksson S, Horecka J, Brustugun OT et al (2008) Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer. Clin Chem 54:582–589",
      "volume": "54",
      "year": "2008"
    },
    {
      "DOI": "10.1136/bmj.d4770",
      "author": "JA Groot de",
      "doi-asserted-by": "crossref",
      "first-page": "d4770",
      "journal-title": "BMJ",
      "key": "9847_CR47",
      "unstructured": "de Groot JA, Bossuyt PM, Reitsma JB et al (2011) Verification problems in diagnostic accuracy studies: consequences and solutions. BMJ 343:d4770. doi: 10.1136/bmj.d4770",
      "volume": "343",
      "year": "2011"
    }
  ],
  "reference-count": 47,
  "references-count": 47,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-015-9847-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Diagnostic values of osteopontin combined with CA125 for ovarian cancer: a meta-analysis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}